MedTrace Logo

Safety and Efficacy of Endovascular Repair of Complex Aortic Pathology With Physician-modified Endovascular Grafts (PMEGs)

NCT04746677 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 220

Last updated 2026-04-08

No results posted yet for this study

Summary

The primary objective of this study is to examine the safety and effectiveness of physician-modified endovascular grafts (PMEGs) for endovascular repair of complex aortic pathology in high-risk patients. The study is divided into three study arms based on the subject's aortic pathology: (1) Complex abdominal aortic aneurysm (AAA); (2) Thoracoabdominal aortic aneurysm; and (3) Aortic dissection.

Conditions

  • Abdominal Aortic Aneurysm
  • Thoracoabdominal Aortic Aneurysm
  • Aortic Dissection

Interventions

DEVICE

Endovascular aortic repair with a physician-modified endovascular graft (PMEG)

Endovascular aortic repair with a physician-modified endovascular graft (PMEG)

DEVICE

TREO graft

Endovascular aortic repair with a physician-modified endovascular graft (PMEG) using the TREO graft

Sponsors & Collaborators

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-15
Primary Completion
2031-03-31
Completion
2031-03-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04746677 on ClinicalTrials.gov